A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran

被引:40
作者
Andersson, Ulf [1 ]
Lindberg, Johan [1 ]
Wang, Shunghuang [3 ]
Balasubramanian, Raji [2 ]
Marcusson-Stahl, Maritha [1 ]
Hannula, Mira [1 ]
Zeng, Chenhui [3 ]
Juhasz, Peter J. [3 ]
Kolmert, Johan [1 ]
Backstrom, Jonas [1 ]
Nord, Lars [1 ]
Nilsson, Kerstin [4 ]
Martin, Steve [3 ]
Glinghammar, Bjorn [1 ]
Cederbrant, Karin [1 ]
Schuppe-Koistinen, Ina [1 ]
机构
[1] AstraZeneca R&D, Safety Assessment, Mol Toxicol, SE-15185 Sodertalje, Sweden
[2] Univ Massachusetts, Shrewsbury, MA USA
[3] BG Med, Waltham, MA 02451 USA
[4] AstraZeneca R&D, Dis Biol, S-15185 Sodertalje, Sweden
关键词
Liver injury; systems biology; alanine aminotransferase; pyruvate; ximelagatran; GCN2 EIF2-ALPHA KINASE; STIMULATING FACTOR-I; PROTEIN-S; C4B-BINDING PROTEIN; PYRUVATE; DRUG; EXPRESSION; RECEPTOR; INJURY; LIVER;
D O I
10.3109/13547500903261354
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ximelagatran was developed for the prevention and treatment of thromboembolic conditions. However, in long-term clinical trials with ximelagatran, the liver injury marker, alanine aminotransferase (ALT) increased in some patients. Analysis of plasma samples from 134 patients was carried out using proteomic and metabolomic platforms, with the aim of finding predictive biomarkers to explain the ALT elevation. Analytes that were changed after ximelagatran treatment included 3-hydroxybutyrate, pyruvic acid, CSF1R, Gc-globulin, L-glutamine, protein S and alanine, etc. Two of these analytes (pyruvic acid and CSF1R) were studied further in human cell cultures in vitro with ximelagatran. A systems biology approach applied in this study proved to be successful in generating new hypotheses for an unknown mechanism of toxicity.
引用
收藏
页码:572 / 586
页数:15
相关论文
共 44 条
[1]  
Albers GW, 2003, LANCET, V362, P1691
[2]   Selection bias in gene extraction on the basis of microarray gene-expression data [J].
Ambroise, C ;
McLachlan, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6562-6566
[3]   Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells [J].
Anderson, HA ;
Maylock, CA ;
Williams, JA ;
Paweletz, CP ;
Shu, HJ ;
Shacter, E .
NATURE IMMUNOLOGY, 2003, 4 (01) :87-91
[4]   Potentiation of hypoxic injury in cultured rabbit hepatocytes by the quinoxalinone anxiolytic, panadiplon [J].
Bacon, JA ;
Cramer, CT ;
Petrella, DK ;
Sun, EL ;
Ulrich, RG .
TOXICOLOGY, 1996, 108 (1-2) :9-16
[5]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[6]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[7]   Colony-stimulating factor-1 in immunity and inflammation [J].
Chitu, V ;
Stanley, ER .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :39-48
[8]   Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model [J].
Davidov, E ;
Clish, CB ;
Oresic, M ;
Meys, M ;
Stochaj, W ;
Snell, P ;
Lavine, G ;
Londo, TR ;
Adourian, A ;
Zhang, X ;
Johnston, M ;
Morel, N ;
Marple, EW ;
Plasterer, TN ;
Neumann, E ;
Verheij, E ;
Vogels, JTWE ;
Havekes, LM ;
Van der Greef, J ;
Naylor, S .
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2004, 8 (04) :267-288
[9]   Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages [J].
DelloSbarba, P ;
Nencioni, L ;
Labardi, D ;
Rovida, E ;
Caciagli, B ;
Cipolleschi, MG .
CYTOKINE, 1996, 8 (06) :488-494
[10]   In vivo clearance of human protein S in a mouse model - Influence of c4b-binding protein and the Heerlen polymorphism [J].
Denis, CV ;
Roberts, SJ ;
Hackeng, TM ;
Lenting, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2209-2215